CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Real life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.
Authors
A Aliyev
M Buyuksimsek
+18 more
D Cabuk
A Demir
Gökçen Demiray
A Dirican
A Gokyer
UM Gunaydin
U Isik
U Kefeli
O Kostek
IN Okten
S Paydas
KN Pilanci
T Sakalar
M Simsek
S Turhal
G Ucar
D Uncu
K Uygun
Publication date
1 January 2019
Publisher
'American Society of Clinical Oncology (ASCO)'
Doi
Cite
Abstract
Abstract is not available.
Similar works
Full text
Available Versions
Pamukkale Üniversitesi Açık Erişim Arşivi
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:acikerisim.pau.edu.tr:1149...
Last time updated on 27/09/2020